Stem Cell Therapy for Diabetes:

Stem cell therapy holds significant promise for the treatment of diabetes, particularly Type 1 Diabetes (T1D), by offering potential solutions for regenerating insulin-producing beta cells in the pancreas. Researchers are exploring the use of stem cells to create functional beta cells from pluripotent or adult stem cells, which could be transplanted into patients to restore insulin production. Another approach is using stem cells to modulate the immune system, preventing the autoimmune attack that destroys beta cells in T1D. While still in the experimental phase, early studies have shown encouraging results in animal models, and clinical trials are underway to assess the safety and effectiveness of stem cell-based therapies. If successful, this could lead to a more permanent solution for diabetes, reducing the need for lifelong insulin therapy.

    Related Conference of Stem Cell Therapy for Diabetes:

    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada

    Stem Cell Therapy for Diabetes: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in